Similar articles for PMID: 25778863

Year	Number of Results
1984	1
1986	1
1988	2
1989	2
1995	1
1996	1
1997	2
2001	1
2002	2
2003	1
2004	1
2005	1
2006	3
2007	4
2008	3
2009	1
2010	4
2011	4
2012	5
2013	10
2014	10
2015	2
2016	2
2017	1
2018	7
2019	3
2020	4
2021	3
2024	0

1

Resolution of alcohol-induced respiratory symptoms following aspirin desensitization in aspirin-exacerbated respiratory disease.

Calais CJ, Banks TA. Calais CJ, et al. Ann Allergy Asthma Immunol. 2015 May;114(5):429-30. doi: 10.1016/j.anai.2015.02.013. Epub 2015 Mar 14. Ann Allergy Asthma Immunol. 2015. PMID: 25778863 No abstract available.

2

Alcohol-induced respiratory symptoms improve after aspirin desensitization in patients with aspirin-exacerbated respiratory disease.

Glicksman JT, Parasher AK, Doghramji L, Brauer D, Waldram J, Walters K, Bulva J, Palmer JN, Adappa ND, White AA, Bosso JV. Glicksman JT, et al. Int Forum Allergy Rhinol. 2018 Oct;8(10):1093-1097. doi: 10.1002/alr.22168. Epub 2018 Jul 10. Int Forum Allergy Rhinol. 2018. PMID: 30007020

3

Aspirin and salicylate in respiratory disease.

Mitchell JE, Skypala I. Mitchell JE, et al. Rhinology. 2013 Sep;51(3):195-205. doi: 10.4193/Rhino12.144. Rhinology. 2013. PMID: 23943725 Review.

4

Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.

Cho KS, Soudry E, Psaltis AJ, Nadeau KC, McGhee SA, Nayak JV, Hwang PH. Cho KS, et al. Otolaryngol Head Neck Surg. 2014 Oct;151(4):575-81. doi: 10.1177/0194599814545750. Epub 2014 Aug 12. Otolaryngol Head Neck Surg. 2014. PMID: 25118195

5

Approach to desensitization in aspirin-exacerbated respiratory disease.

Scott DR, White AA. Scott DR, et al. Ann Allergy Asthma Immunol. 2014 Jan;112(1):13-7. doi: 10.1016/j.anai.2013.09.011. Ann Allergy Asthma Immunol. 2014. PMID: 24331387 Review. No abstract available.

6

Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.

Lee RU, White AA, Ding D, Dursun AB, Woessner KM, Simon RA, Stevenson DD. Lee RU, et al. Ann Allergy Asthma Immunol. 2010 Aug;105(2):130-5. doi: 10.1016/j.anai.2010.05.020. Epub 2010 Jul 1. Ann Allergy Asthma Immunol. 2010. PMID: 20674823

7

[Aspirin-exacerbated respiratory disease].

Randerath WJ. Randerath WJ. Dtsch Med Wochenschr. 2013 Mar;138(11):541-7. doi: 10.1055/s-0032-1332934. Epub 2013 Mar 5. Dtsch Med Wochenschr. 2013. PMID: 23463477 Review. German.

8

Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease.

Tyrak KE, Pajdzik K, Jakieła B, Kupryś-Lipińska I, Ćmiel A, Kacorzyk R, Trąd G, Kuna P, Sanak M, Mastalerz L. Tyrak KE, et al. Clin Exp Allergy. 2021 Aug;51(8):1046-1056. doi: 10.1111/cea.13886. Epub 2021 May 11. Clin Exp Allergy. 2021. PMID: 33905579 Free PMC article.

9

Desensitisation to aspirin in antiphospholipid antibody syndrome.

Cernadas JR, Leblanc A, de Castro ED. Cernadas JR, et al. Allergol Immunopathol (Madr). 2013 Nov-Dec;41(6):420-2. doi: 10.1016/j.aller.2012.07.013. Epub 2012 Dec 20. Allergol Immunopathol (Madr). 2013. PMID: 23265266 No abstract available.

10

Evidence-based approach to aspirin desensitization in aspirin-exacerbated respiratory disease.

Woessner KM, White AA. Woessner KM, et al. J Allergy Clin Immunol. 2014 Jan;133(1):286-7.e1-9. doi: 10.1016/j.jaci.2013.11.016. J Allergy Clin Immunol. 2014. PMID: 24369807 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year